Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Sales (2020 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Return on Sales for 6 consecutive years, with 0.09% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 15.0% to 0.09% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.18% through Dec 2025, down 2.0% year-over-year, with the annual reading at 0.18% for FY2025, 2.0% down from the prior year.
  • Return on Sales hit 0.09% in Q4 2025 for Harmony Biosciences Holdings, down from 0.21% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.75% in Q3 2022 to a low of 0.12% in Q3 2021.
  • Historically, Return on Sales has averaged 0.22% across 5 years, with a median of 0.24% in 2023.
  • Biggest five-year swings in Return on Sales: soared 207bps in 2021 and later plummeted -51bps in 2023.
  • Year by year, Return on Sales stood at 0.25% in 2021, then skyrocketed by 52bps to 0.38% in 2022, then crashed by -79bps to 0.08% in 2023, then soared by 214bps to 0.25% in 2024, then plummeted by -62bps to 0.09% in 2025.
  • Business Quant data shows Return on Sales for HRMY at 0.09% in Q4 2025, 0.21% in Q3 2025, and 0.2% in Q2 2025.